The present disclosure provides SPNS2 inhibitor compounds according to Formula I and their pharmaceutically acceptable salts, and/or tautomers as described in the disclosure, and the disclosure provides their pharmaceutical compositions and methods of use in therapy.
本公开提供了根据公式I提供的
SPNS2
抑制剂化合物及其药学上可接受的盐,以及/或在公开中描述的互变异构体,并且公开提供了它们的药物组合物以及在治疗中使用的方法。